PPT Slide
PROTECT Trial showed safety profile of the eligen™ technology and effectiveness of oral form
Submitted trial results to FDA under our previously filed IND
Planning strategy for product registration
- Bioequivalence of solid form to liquid
- Choose indication
- Request meeting with FDA to discuss registration and strategy